DE60012288D1 - Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung - Google Patents

Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung

Info

Publication number
DE60012288D1
DE60012288D1 DE60012288T DE60012288T DE60012288D1 DE 60012288 D1 DE60012288 D1 DE 60012288D1 DE 60012288 T DE60012288 T DE 60012288T DE 60012288 T DE60012288 T DE 60012288T DE 60012288 D1 DE60012288 D1 DE 60012288D1
Authority
DE
Germany
Prior art keywords
pyrimidindion
antiviral
derivatives
production
pyrimidindion derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60012288T
Other languages
English (en)
Other versions
DE60012288T2 (de
Inventor
Eui-Hwan Cho
Sun-Gan Chung
Sun-Hwan Lee
Ho-Seok Kwon
Jae-Eung Lee
Jeong-Ho Joo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Samjin Pharmaceutical Co Ltd
Original Assignee
Samjin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Samjin Pharmaceutical Co Ltd filed Critical Samjin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60012288D1 publication Critical patent/DE60012288D1/de
Publication of DE60012288T2 publication Critical patent/DE60012288T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE60012288T 1999-04-10 2000-04-08 Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung Expired - Lifetime DE60012288T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR9912629 1999-04-10
KR1019990012629A KR20000065885A (ko) 1999-04-10 1999-04-10 항바이러스성 피리미딘다이온 유도체 및 그 제조방법
PCT/KR2000/000328 WO2000061564A1 (en) 1999-04-10 2000-04-08 Antiviral pyrimidinedione derivatives and process for the preparation thereof

Publications (2)

Publication Number Publication Date
DE60012288D1 true DE60012288D1 (de) 2004-08-26
DE60012288T2 DE60012288T2 (de) 2005-08-18

Family

ID=19579308

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60012288T Expired - Lifetime DE60012288T2 (de) 1999-04-10 2000-04-08 Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung

Country Status (11)

Country Link
US (1) US6987114B1 (de)
EP (1) EP1100786B1 (de)
JP (1) JP3539926B2 (de)
KR (2) KR20000065885A (de)
CN (1) CN1169797C (de)
AU (1) AU760332B2 (de)
CA (1) CA2334317C (de)
DE (1) DE60012288T2 (de)
RU (1) RU2203891C2 (de)
WO (2) WO2000061563A1 (de)
ZA (1) ZA200007308B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6713486B1 (en) * 1999-03-04 2004-03-30 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof
NZ549716A (en) * 2004-03-15 2010-04-30 Takeda Pharmaceutical Pyrimidin-dione derivatives as dipeptidyl peptidase inhibitors
JP5031564B2 (ja) * 2004-08-10 2012-09-19 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｈｉｖ抑制１，２，４−トリアジン−６−オン誘導体
KR101237312B1 (ko) * 2006-02-10 2013-03-04 삼진제약주식회사 피리미딘다이온 유도체를 포함하는 ｃ형 간염의 예방 및치료용 약학 조성물
KR101257378B1 (ko) * 2006-04-19 2013-04-23 삼진제약주식회사 항바이러스성 피리미딘디온 유도체 및 이의 제조 방법
AU2007281604A1 (en) 2006-07-24 2008-02-07 Korea Research Institute Of Chemical Technology HIV reverse transcriptase inhibitors
WO2009005693A1 (en) 2007-06-29 2009-01-08 Gilead Sciences, Inc. Novel hiv reverse transcriptase inhibitors
EA200971115A1 (ru) * 2007-06-29 2010-04-30 Корея Рисерч Инститьют Оф Кемикал Текнолоджи Новые ингибиторы обратной транскриптазы вич
KR20100092960A (ko) 2007-12-21 2010-08-23 한국화학연구원 Ｈｉｖ 역전사 효소 억제제의 제조 방법
MX2012012353A (es) * 2010-04-23 2013-02-07 Kineta Inc Compuestos anti-virales.
EP2574924A1 (de) 2011-09-28 2013-04-03 Merck Patent GmbH Verfahren zur Bestimmung des Status von Zellen
SG11201401082XA (en) * 2011-09-30 2014-04-28 Kineta Inc Anti-viral compounds
WO2014043252A2 (en) * 2012-09-11 2014-03-20 Rutgers, The State University Of New Jersey Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
CN109761911A (zh) * 2019-02-16 2019-05-17 安徽诺全药业有限公司 一种用作Elagolix中间体的多取代嘧啶衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4730001A (en) * 1986-01-22 1988-03-08 Southern Research Institute Carbocyclic analogues of amino and azido thymidines
HU205917B (en) * 1989-09-29 1992-07-28 Mitsubishi Chem Ind Process for producing 6-substituted pyrimidine derivatives and antiviral pharmaceutical compositions containing them as active components
KR0151811B1 (ko) * 1993-12-21 1998-10-15 강박광 신규한 항바이러스성 2,4-피리미딘디온 유도체 및 그의 제조방법
CN1092647C (zh) * 1996-02-22 2002-10-16 三进制药株式会社 新抗病毒的取代嘧啶二酮同素碳环核苷衍生物及其制备方法与含有其为活性成分的组合物
KR100219922B1 (ko) * 1996-05-16 1999-09-01 이서봉 신규한 항바이러스성 6-아릴옥시 및 6-아릴카르보닐 2,4-피리미딘디온 유도체 및 그의 제조 방법
US6713486B1 (en) * 1999-03-04 2004-03-30 Korea Research Institute Of Chemical Technology Antiviral 2,4-pyrimidinedione derivatives and process for the preparation thereof

Also Published As

Publication number Publication date
DE60012288T2 (de) 2005-08-18
AU760332B2 (en) 2003-05-15
KR100425281B1 (ko) 2004-03-30
EP1100786B1 (de) 2004-07-21
AU4147000A (en) 2000-11-14
WO2000061563A1 (en) 2000-10-19
RU2203891C2 (ru) 2003-05-10
ZA200007308B (en) 2001-06-11
EP1100786A1 (de) 2001-05-23
KR20010052737A (ko) 2001-06-25
CA2334317C (en) 2004-05-18
KR20000065885A (ko) 2000-11-15
JP2002541246A (ja) 2002-12-03
CN1169797C (zh) 2004-10-06
CN1313854A (zh) 2001-09-19
US6987114B1 (en) 2006-01-17
WO2000061564A1 (en) 2000-10-19
CA2334317A1 (en) 2000-10-19
JP3539926B2 (ja) 2004-07-07

Similar Documents

Publication Publication Date Title
DE60031949D1 (de) Leiterplatte und verfahren zu ihrer herstellung
DE69929311D1 (de) Oximanderivate und verfahren zu ihrer herstellung
DE60027698D1 (de) Lasttragendes osteoimplantat und verfahren zu seiner herstellung
DE69922815D1 (de) Gipsplatte und verfahren zu ihrer herstellung
ATE263754T1 (de) Substituierte sulfonylaminomethylbenzoesäure(derivate) und verfahren zu ihrer herstellung
DE60023023D1 (de) Zirkoniumdioxidsol und verfahren zu seiner herstellung
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DE60033028D1 (de) 5-pyridyl-1,3-azol-derivate, verfahren zu ihrer herstellung und ihre verwendung
DE60036294D1 (de) Umgossener transponder und verfahren zu dessen herstellung
DE69942382D1 (de) Sensor und verfahren zu dessen herstellung
DE60017552D1 (de) Geschaeumte schokolade und verfahren zu dessen herstellung
ATE288577T1 (de) Ladeluftkühler und verfahren zu dessen herstellung
DE60024801D1 (de) Polyurethanharnstofffasern und verfahren zu ihrer herstellung
DE60010988D1 (de) Piperazinderivate und verfahren zu ihrer herstellung
DE69932361D1 (de) Trennschicht und verfahren zu deren herstellung
ATE241613T1 (de) Pyrimidinderivate und verfahren zu deren herstellung
ATE296535T1 (de) Wässerige formulierungen und verfahren zu ihrer herstellung
DE60012288D1 (de) Antivirale pyrimidindion-derivate und verfahren zu ihrer herstellung
DE69625176D1 (de) Camptothecin-derivate und verfahren zu ihrer herstellung
DE69801795T2 (de) Indolyl-pyrrolylidenmethylpyrrol-derivate und verfahren zu ihrer herstellung
DE50010354D1 (de) Verbundteil und verfahren zu dessen herstellung
DE60040411D1 (de) Gerter freigabe und verfahren zu ihrer herstellung
DE60123292D1 (de) Uht-milchkonzentratspackung und verfahren zu ihrer herstellung
DE60038384D1 (de) Polyarylen und verfahren zu dessen herstellung
DE69905326T2 (de) Sollerschlitz und Verfahren zu dessen Herstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition